Incretin Integration Starts Here

Tirzepatide is a lab-designed peptide developed in the 2010s to study how two key metabolic signals, GIP and GLP-1 work together.

Instead of targeting a single pathway, it combines both into one molecule, allowing researchers to explore how the body coordinates appetite, insulin signaling, and energy use in a more integrated and realistic way.

Each lot includes:

• Batch-specific COA with QR code verification
• Purity: ≥98% verified by third-party HPLC
• Identity: confirmed via mass spectrometry
• Endotoxin, sterility, and heavy-metal screening
• Full traceability from synthesis to shipment